Literature DB >> 14531808

Iron handling and gene expression of the divalent metal transporter, DMT1, in the kidney of the anemic Belgrade (b) rat.

Carole J Ferguson1, Mark Wareing, Mathieu Delannoy, Robert Fenton, Stuart J McLarnon, Nicholas Ashton, Alan G Cox, Raymond F T McMahon, Laura M Garrick, Roger Green, Craig P Smith, Daniela Riccardi.   

Abstract

BACKGROUND: We have previously shown that the rat kidney reabsorbs metabolically significant amounts of iron and that it expresses the divalent metal transporter 1, DMT1. The Belgrade (b) rat carries a mutation in DMT1 gene, which causes hypochromic, microcytic anemia due to impaired intestinal iron absorption and transport of iron out of the transferrin cycle endosome. In the duodenum of b/b rats, expression of DMT1 mRNA and protein is increased, suggesting a feedback regulation by iron stores. The aim of this study was to investigate iron handling and DMT1 expression in the kidneys of Belgrade rats.
METHODS: Animals were maintained for 3 weeks on a synthetic diet containing 185 mg/kg iron (FeSO4), after which functional and molecular parameters were analyzed in male heterozygous (+/b) and homozygous (b/b) rats (N = 4 to 6 for each group).
RESULTS: Serum iron concentration was significantly higher in b/b compared to +/b rats while urinary iron excretion rates were unchanged in b/b compared to +/b rats. Northern analysis using a rat DMT1 probe showed comparable mRNA levels between +/b and b/b animals. Western analysis and immunofluorescence microscopy performed using a polyclonal antibody against rat DMT1 showed that DMT1-specific immunoreactivity was almost absent in the kidneys of b/b rats compared to that seen in +/b animals.
CONCLUSION: Our results indicate that the G185R mutation of DMT1 causes protein instability in the kidneys of b/b rats. Given that +/b and b/b rats excrete comparable amounts of iron, the lack of DMT1 protein is compensated by an alternative, yet to be identified, mechanism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14531808     DOI: 10.1046/j.1523-1755.2003.00274.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

1.  Transport of iron chelators and chelates across MDCK cell monolayers: implications for iron excretion during chelation therapy.

Authors:  Xi-Ping Huang; Jake J Thiessen; Michael Spino; Douglas M Templeton
Journal:  Int J Hematol       Date:  2010-03-09       Impact factor: 2.490

Review 2.  Manganese neurotoxicity: a focus on the neonate.

Authors:  Keith M Erikson; Khristy Thompson; Judy Aschner; Michael Aschner
Journal:  Pharmacol Ther       Date:  2006-09-22       Impact factor: 12.310

3.  Glucose metabolism in the Belgrade rat, a model of iron-loading anemia.

Authors:  Xuming Jia; Jonghan Kim; Tania Veuthey; Chih-Hao Lee; Marianne Wessling-Resnick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-04-18       Impact factor: 4.052

Review 4.  H(+)-coupled divalent metal-ion transporter-1: functional properties, physiological roles and therapeutics.

Authors:  Ali Shawki; Patrick B Knight; Bryan D Maliken; Eric J Niespodzany; Bryan Mackenzie
Journal:  Curr Top Membr       Date:  2012       Impact factor: 3.049

5.  Impaired renal function and development in Belgrade rats.

Authors:  Tania Veuthey; Dana Hoffmann; Vishal S Vaidya; Marianne Wessling-Resnick
Journal:  Am J Physiol Renal Physiol       Date:  2013-11-13

Review 6.  Mechanisms of divalent metal toxicity in affective disorders.

Authors:  Archita Venugopal Menon; JuOae Chang; Jonghan Kim
Journal:  Toxicology       Date:  2015-11-10       Impact factor: 4.221

7.  Regulation of DMT1 on Bone Microstructure in Type 2 Diabetes.

Authors:  Wei-Lin Zhang; Hong-Zheng Meng; Mao-Wei Yang
Journal:  Int J Med Sci       Date:  2015-05-26       Impact factor: 3.738

Review 8.  Pathophysiology of the Belgrade rat.

Authors:  Tania Veuthey; Marianne Wessling-Resnick
Journal:  Front Pharmacol       Date:  2014-04-22       Impact factor: 5.810

9.  Erythropoiesis-independent effects of iron in chronic kidney disease.

Authors:  Edwin Patino; Oleh Akchurin
Journal:  Pediatr Nephrol       Date:  2021-07-09       Impact factor: 3.651

10.  Iron chelation by deferoxamine prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction.

Authors:  Yasumasa Ikeda; Iori Ozono; Soichiro Tajima; Mizuki Imao; Yuya Horinouchi; Yuki Izawa-Ishizawa; Yoshitaka Kihira; Licht Miyamoto; Keisuke Ishizawa; Koichiro Tsuchiya; Toshiaki Tamaki
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.